Scholars Central

Conference abstractPublished 28 Jul 2014

Elevated serum IgG4 defines a specific clinical phenotype of Rheumatoid arthritis

Authors: Lie Dai, Le-Feng Chen, Ying-Qian Mo, Jian-Da Ma, Ling Luo, Dong-Hui Zheng

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Rheumatoid arthritis (RA) is a heterogeneous autoimmune disease and subtyping of RA may help optimal therapeutic strategies and outcome prediction. There is no available satisfying classification method until now. Recently, much attention has been paid to IgG4 since the recognition of IgG4-related disease, a new emerging disease entity. Elevated serum IgG4 (sIgG4) was also reported in some RA patients. However, the clinical significance of elevated sIgG4 in RA remains elusive. Objectives: To explore the correlation of sIgG4 with disease activity and therapeutic response in RA. Methods: Consecutive 114 RA patients with active disease (DAS28 ≥2.6) were recruited and all patients were followed up at regular interval (1, 3, and 6 months). SIgG4 were detected by immunonephelometry at baseline and sIgG4≥1.35 g/L was considered as elevated. Results: 1. Among 114 RA patients, 60% were female and median age was 57 years. The mean sIgG4 was 1.63±1.32g/L, with 48% had elevated sIgG4. The mean sIgG4/sIgG ratio was 10.5%±7.6%, with 55% had elevated sIgG4/sIgG ratio (≥8%), and 95% of patients with elevated sIgG4 accompanied by elevated sIgG4/sIgG ratio. 2. Patients with elevated sIgG4 had higher PtGA, PrGA, CRP and ESR than those with normal sIgG4 (all P 0.05). After 6 months treatment, RF level of patients with elevated sIgG4 were significantly lower than those with normal sIgG4, and the declined ratio of RF of patients with elevated sIgG4 were significantly higher than those with normal sIgG4 (both P<0.05). Conclusions: Obtained results showed that elevated sIgG4 in RA is common and disproportional to total IgG and RA with elevated sIgG4 may be a specific clinical phenotype with higher disease activity, higher level of autoantibodies, and poor response to MTX + LEF therapy

Subjects

Orthopaedics

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalOrthopedic & Muscular System: Current Research
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Lie Dai”
  • BylineArticles whose byline prints “Le-Feng Chen”
  • BylineArticles whose byline prints “Ying-Qian Mo”
  • BylineArticles whose byline prints “Jian-Da Ma”
  • BylineArticles whose byline prints “Ling Luo”
  • BylineArticles whose byline prints “Dong-Hui Zheng”